$NKTR
Nektar Therapeutics

2013 Q1 Form 10-K Financial Statement

#000119312513085500 Filed on March 01, 2013

View on sec.gov

Income Statement

Concept 2013 Q1 2011 Q4 2011 Q3
Revenue $23.00M $15.78M $27.07M
YoY Change 28.16% -65.16% -28.58%
Cost Of Revenue $11.66M $5.450M $5.038M
YoY Change 33.93% -46.57% -18.74%
Gross Profit $11.34M $10.33M $22.03M
YoY Change 22.73% -70.56% -30.5%
Gross Profit Margin 49.31% 65.47% 81.39%
Selling, General & Admin $10.80M $11.50M $12.40M
YoY Change 3.85% -0.86% 21.57%
% of Gross Profit 95.21% 111.3% 56.29%
Research & Development $45.62M $33.30M $31.02M
YoY Change 30.02% 5.72% 11.98%
% of Gross Profit 402.17% 322.32% 140.8%
Depreciation & Amortization $3.600M $3.600M $3.800M
YoY Change 2.86% -12.2% -9.52%
% of Gross Profit 31.74% 34.84% 17.25%
Operating Expenses $45.62M $33.30M $31.02M
YoY Change 30.02% -22.73% -18.37%
Operating Profit -$45.11M -$34.47M -$21.34M
YoY Change 18.91% 330.85% 238.7%
Interest Expense $4.645M -$2.300M $2.543M
YoY Change 82.3% 27.78% -215.59%
% of Operating Profit
Other Income/Expense, Net -$9.747M -$2.638M
YoY Change 220.52%
Pretax Income -$54.85M -$36.80M -$23.98M
YoY Change 33.87% 65.02% 185.43%
Income Tax $212.0K $700.0K $92.00K
% Of Pretax Income
Net Earnings -$55.06M -$37.50M -$24.07M
YoY Change 33.98% 65.91% 176.64%
Net Earnings / Revenue -239.36% -237.58% -88.92%
Basic Earnings Per Share -$0.48
Diluted Earnings Per Share -$0.48 -$327.8K -$210.7K
COMMON SHARES
Basic Shares Outstanding 115.3M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2013 Q1 2011 Q4 2011 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $236.2M $241.2M $266.5M
YoY Change -38.18% -23.65% -12.13%
Cash & Equivalents $28.53M $15.31M $43.01M
Short-Term Investments $207.7M $225.9M $223.5M
Other Short-Term Assets $8.813M $17.94M $7.600M
YoY Change -35.2% 214.81% 24.59%
Inventory $18.38M $12.66M $10.70M
Prepaid Expenses
Receivables $3.647M $4.938M $12.90M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $267.0M $276.7M $297.6M
YoY Change -36.53% -21.83% -8.82%
LONG-TERM ASSETS
Property, Plant & Equipment $70.11M $78.58M $81.60M
YoY Change -7.26% -12.5% -16.48%
Goodwill $76.50M $76.50M
YoY Change
Intangibles
YoY Change
Long-Term Investments $173.8M $191.5M
YoY Change
Other Assets $9.252M $999.0K $800.0K
YoY Change 74.57% -0.1% -57.89%
Total Long-Term Assets $180.9M $329.8M $350.5M
YoY Change -34.01% 97.28% 99.03%
TOTAL ASSETS
Total Short-Term Assets $267.0M $276.7M $297.6M
Total Long-Term Assets $180.9M $329.8M $350.5M
Total Assets $447.9M $606.6M $648.1M
YoY Change -35.54% 16.38% 28.98%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $4.218M $3.019M $2.200M
YoY Change 134.33% -58.07% -50.0%
Accrued Expenses $6.946M $6.669M $37.10M
YoY Change -75.8% -77.7% 3.92%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $215.0M $215.0M
YoY Change -100.0%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $83.22M $275.5M $279.0M
YoY Change -69.27% 329.85% 229.01%
LONG-TERM LIABILITIES
Long-Term Debt $135.8M $14.60M $15.30M
YoY Change -2.79% -93.71% -93.42%
Other Long-Term Liabilities $9.015M $7.159M $123.0M
YoY Change -92.6% -94.68% 57.09%
Total Long-Term Liabilities $9.015M $7.159M $138.3M
YoY Change -96.55% -98.05% -55.49%
TOTAL LIABILITIES
Total Short-Term Liabilities $83.22M $275.5M $279.0M
Total Long-Term Liabilities $9.015M $7.159M $138.3M
Total Liabilities $450.5M $408.7M $417.3M
YoY Change -15.36% -5.08% 5.51%
SHAREHOLDERS EQUITY
Retained Earnings -$1.625B -$1.399B
YoY Change
Common Stock $1.623B $1.597B
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$2.620M $197.8M $230.8M
YoY Change
Total Liabilities & Shareholders Equity $447.9M $606.6M $648.1M
YoY Change -35.54% 16.38% 28.98%

Cashflow Statement

Concept 2013 Q1 2011 Q4 2011 Q3
OPERATING ACTIVITIES
Net Income -$55.06M -$37.50M -$24.07M
YoY Change 33.98% 65.91% 176.64%
Depreciation, Depletion And Amortization $3.600M $3.600M $3.800M
YoY Change 2.86% -12.2% -9.52%
Cash From Operating Activities -$38.11M -$42.20M -$21.80M
YoY Change 10.09% -306.86% -1.8%
INVESTING ACTIVITIES
Capital Expenditures $316.0K -$1.400M -$1.500M
YoY Change -79.16% -84.95% -88.81%
Acquisitions
YoY Change
Other Investing Activities $44.00M $15.90M $54.10M
YoY Change -11.82% -303.85% 118.15%
Cash From Investing Activities $43.69M $14.40M $52.70M
YoY Change -9.79% -183.72% 358.26%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -2.474M -300.0K 0.000
YoY Change -102.07% -120.0% -100.0%
NET CHANGE
Cash From Operating Activities -38.11M -42.20M -21.80M
Cash From Investing Activities 43.69M 14.40M 52.70M
Cash From Financing Activities -2.474M -300.0K 0.000
Net Change In Cash 3.101M -28.10M 30.90M
YoY Change -97.67% -697.87% -405.94%
FREE CASH FLOW
Cash From Operating Activities -$38.11M -$42.20M -$21.80M
Capital Expenditures $316.0K -$1.400M -$1.500M
Free Cash Flow -$38.43M -$40.80M -$20.30M
YoY Change 6.35% -237.37% 130.68%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2011Q4 nktr Additional Area Included In Operating Sublease After Amendment
AdditionalAreaIncludedInOperatingSubleaseAfterAmendment
24002 sqft
CY2013Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
115289548 shares
CY2012Q2 dei Entity Public Float
EntityPublicFloat
922720854
CY2012Q3 nktr Amount Kept In Reserve Account
AmountKeptInReserveAccount
25000000
CY2012Q3 nktr Convertible Subordinated Notes Remaining
ConvertibleSubordinatedNotesRemaining
172400000
CY2009Q3 nktr Operating Sublease
OperatingSublease
102283 sqft
CY2009Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
13084000
CY2009Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
49597000
CY2009Q4 us-gaap Stockholders Equity
StockholdersEquity
102367000
CY2010Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
13058000
CY2010Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
17755000
CY2010Q4 us-gaap Stockholders Equity
StockholdersEquity
90662000
CY2011Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
490689000
CY2011Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
300000000 shares
CY2011Q4 us-gaap Other Assets Current
OtherAssetsCurrent
17944000
CY2011Q4 us-gaap Deferred Tax Assets Deferred Income
DeferredTaxAssetsDeferredIncome
48732000
CY2011Q4 us-gaap Available For Sale Securities
AvailableForSaleSecurities
399624000
CY2011Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
12807000
CY2011Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
13576000
CY2011Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2011Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-1103000
CY2011Q4 us-gaap Liabilities Current
LiabilitiesCurrent
275532000
CY2011Q4 us-gaap Deferred Tax Liabilities
DeferredTaxLiabilities
75000
CY2011Q4 us-gaap Inventory Work In Process
InventoryWorkInProcess
4313000
CY2011Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
19643000
CY2011Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-1398525000
CY2011Q4 us-gaap Assets
Assets
606550000
CY2011Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
15312000
CY2011Q4 us-gaap Inventory Raw Materials
InventoryRawMaterials
6660000
CY2011Q4 us-gaap Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
75000
CY2011Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
62000
CY2011Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
4938000
CY2011Q4 us-gaap Inventory Net
InventoryNet
12656000
CY2011Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
CY2011Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
137000
CY2011Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
999000
CY2011Q4 us-gaap Convertible Subordinated Debt Current
ConvertibleSubordinatedDebtCurrent
214955000
CY2011Q4 us-gaap Line Of Credit Facility Amount Outstanding
LineOfCreditFacilityAmountOutstanding
2400000
CY2011Q4 us-gaap Available For Sale Securities Current
AvailableForSaleSecuritiesCurrent
225856000
CY2011Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
342128000
CY2011Q4 us-gaap Capital Leased Assets Gross
CapitalLeasedAssetsGross
2312000
CY2011Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
606550000
CY2011Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
114485000 shares
CY2011Q4 us-gaap Common Stock Value
CommonStockValue
11000
CY2011Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2011Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
490826000
CY2011Q4 us-gaap Goodwill
Goodwill
76501000
CY2011Q4 us-gaap Available For Sale Securities Noncurrent
AvailableForSaleSecuritiesNoncurrent
173768000
CY2011Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
4681000
CY2011Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
19268000
CY2011Q4 us-gaap Liabilities
Liabilities
408739000
CY2011Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
3895000
CY2011Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2011Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
6669000
CY2011Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
1683000
CY2011Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2011Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2011Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
78576000
CY2011Q4 us-gaap Available For Sale Securities Debt Maturities Within One Year Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
213386000
CY2011Q4 us-gaap Other Deferred Credits Noncurrent
OtherDeferredCreditsNoncurrent
3278000
CY2011Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2011Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
114485000 shares
CY2011Q4 us-gaap Capital Leases Balance Sheet Assets By Major Class Net
CapitalLeasesBalanceSheetAssetsByMajorClassNet
1848000
CY2011Q4 us-gaap Interest Payable Current
InterestPayableCurrent
1805000
CY2011Q4 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
108188000
CY2011Q4 us-gaap Assets Current
AssetsCurrent
276706000
CY2011Q4 us-gaap Construction In Progress Gross
ConstructionInProgressGross
1750000
CY2011Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2011Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
62237000
CY2011Q4 us-gaap Available For Sale Securities Fair Value Disclosure
AvailableForSaleSecuritiesFairValueDisclosure
399624000
CY2011Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
1597428000
CY2011Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards Research
DeferredTaxAssetsTaxCreditCarryforwardsResearch
51125000
CY2011Q4 us-gaap Stockholders Equity
StockholdersEquity
197811000
CY2011Q4 us-gaap Capital Lease Obligations Noncurrent
CapitalLeaseObligationsNoncurrent
14582000
CY2011Q4 us-gaap Capital Leases Lessee Balance Sheet Assets By Major Class Accumulated Deprecation
CapitalLeasesLesseeBalanceSheetAssetsByMajorClassAccumulatedDeprecation
464000
CY2011Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
7159000
CY2011Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals
8083000
CY2011Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
3019000
CY2011Q4 nktr Available For Sale Securities Debt Maturities After One Through Two Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughTwoYearsFairValue
186238000
CY2011Q4 nktr Number Of Customers Accounted For Major Accounts Receivable
NumberOfCustomersAccountedForMajorAccountsReceivable
4 Customer
CY2011Q4 nktr Estimated Fair Value Of Cash Cash Equivalents And Available For Sale Investments
EstimatedFairValueOfCashCashEquivalentsAndAvailableForSaleInvestments
414936000
CY2011Q4 nktr Depreciable Property Plant And Equipment Gross
DepreciablePropertyPlantAndEquipmentGross
139063000
CY2011Q4 nktr Depreciable Property Plant And Equipment Net
DepreciablePropertyPlantAndEquipmentNet
76826000
CY2011Q4 nktr Deferred Tax Assets Capitalized Research Expenses
DeferredTaxAssetsCapitalizedResearchExpenses
9514000
CY2011Q4 nktr Deferred Tax Assets Depreciation Property And Equipment
DeferredTaxAssetsDepreciationPropertyAndEquipment
8081000
CY2011Q4 nktr Liability Related To Sale Of Potential Future Royalties
LiabilityRelatedToSaleOfPotentialFutureRoyalties
CY2011Q4 nktr Accrued Clinical Trial Expenses
AccruedClinicalTrialExpenses
11953000
CY2011Q4 nktr Preferred Stock Share Designated
PreferredStockShareDesignated
3100000 shares
CY2011Q4 nktr Cash And Money Market Funds Including Restricted Cash
CashAndMoneyMarketFundsIncludingRestrictedCash
15312000
CY2012Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
534268000
CY2012Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
300000000 shares
CY2012Q4 us-gaap Other Assets Current
OtherAssetsCurrent
13363000
CY2012Q4 us-gaap Capital Leases Future Minimum Payments Due In Four Years
CapitalLeasesFutureMinimumPaymentsDueInFourYears
4034000
CY2012Q4 us-gaap Deferred Tax Assets Deferred Income
DeferredTaxAssetsDeferredIncome
39521000
CY2012Q4 us-gaap Available For Sale Securities
AvailableForSaleSecurities
251757000
CY2012Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
8773000
CY2012Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
14067000
CY2012Q4 us-gaap Senior Long Term Notes
SeniorLongTermNotes
125000000
CY2012Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2012Q4 us-gaap Operating Leases Future Minimum Payments Due Thereafter
OperatingLeasesFutureMinimumPaymentsDueThereafter
8479000
CY2012Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-357000
CY2012Q4 us-gaap Liabilities Current
LiabilitiesCurrent
78537000
CY2012Q4 us-gaap Inventory Work In Process
InventoryWorkInProcess
6661000
CY2012Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
21896000
CY2012Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-1570380000
CY2012Q4 us-gaap Assets
Assets
497790000
CY2012Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
25437000
CY2012Q4 us-gaap Inventory Raw Materials
InventoryRawMaterials
7489000
CY2012Q4 us-gaap Significant Purchase Commitment Remaining Minimum Amount Committed
SignificantPurchaseCommitmentRemainingMinimumAmountCommitted
14600000
CY2012Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
95000
CY2012Q4 us-gaap Capital Leases Future Minimum Payments Present Value Of Net Minimum Payments
CapitalLeasesFutureMinimumPaymentsPresentValueOfNetMinimumPayments
14577000
CY2012Q4 us-gaap Operating Leases Future Minimum Payments Due In Five Years
OperatingLeasesFutureMinimumPaymentsDueInFiveYears
3888000
CY2012Q4 us-gaap Undistributed Earnings Of Foreign Subsidiaries
UndistributedEarningsOfForeignSubsidiaries
3100000
CY2012Q4 us-gaap Capital Leases Future Minimum Payments Due In Three Years
CapitalLeasesFutureMinimumPaymentsDueInThreeYears
5280000
CY2012Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
5805000
CY2012Q4 us-gaap Inventory Net
InventoryNet
18269000
CY2012Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
CY2012Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
95000
CY2012Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
9443000
CY2012Q4 us-gaap Convertible Subordinated Debt Current
ConvertibleSubordinatedDebtCurrent
CY2012Q4 us-gaap Line Of Credit Facility Amount Outstanding
LineOfCreditFacilityAmountOutstanding
2400000
CY2012Q4 us-gaap Available For Sale Securities Current
AvailableForSaleSecuritiesCurrent
251757000
CY2012Q4 us-gaap Capital Leases Future Minimum Payments Due In Two Years
CapitalLeasesFutureMinimumPaymentsDueInTwoYears
5191000
CY2012Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
351354000
CY2012Q4 us-gaap Capital Leased Assets Gross
CapitalLeasedAssetsGross
2312000
CY2012Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
497790000
CY2012Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
115259000 shares
CY2012Q4 us-gaap Capital Leases Future Minimum Payments Interest Included In Payments
CapitalLeasesFutureMinimumPaymentsInterestIncludedInPayments
5057000
CY2012Q4 us-gaap Common Stock Value
CommonStockValue
11000
CY2012Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
23746000
CY2012Q4 us-gaap Liabilities
Liabilities
450772000
CY2012Q4 us-gaap Operating Leases Future Minimum Payments Due In Two Years
OperatingLeasesFutureMinimumPaymentsDueInTwoYears
1509000
CY2012Q4 us-gaap Goodwill
Goodwill
76501000
CY2012Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
12414000
CY2012Q4 us-gaap Operating Leases Future Minimum Payments Due In Three Years
OperatingLeasesFutureMinimumPaymentsDueInThreeYears
3667000
CY2012Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2012Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
534363000
CY2012Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
2773000
CY2012Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2012Q4 us-gaap Capital Lease Obligations Current
CapitalLeaseObligationsCurrent
2970000
CY2012Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
8008000
CY2012Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
4119000
CY2012Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2012Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2012Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
72215000
CY2012Q4 us-gaap Operating Leases Future Minimum Payments Due Current
OperatingLeasesFutureMinimumPaymentsDueCurrent
200000
CY2012Q4 us-gaap Available For Sale Securities Debt Maturities Within One Year Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
251757000
CY2012Q4 us-gaap Other Deferred Credits Noncurrent
OtherDeferredCreditsNoncurrent
2404000
CY2012Q4 us-gaap Restricted Cash And Investments Noncurrent
RestrictedCashAndInvestmentsNoncurrent
25000000
CY2012Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2012Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
115259000 shares
CY2012Q4 us-gaap Capital Leases Future Minimum Payments Due
CapitalLeasesFutureMinimumPaymentsDue
19634000
CY2012Q4 us-gaap Capital Leases Balance Sheet Assets By Major Class Net
CapitalLeasesBalanceSheetAssetsByMajorClassNet
1430000
CY2012Q4 us-gaap Interest Payable Current
InterestPayableCurrent
7083000
CY2012Q4 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
96551000
CY2012Q4 us-gaap Assets Current
AssetsCurrent
314631000
CY2012Q4 us-gaap Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
21520000
CY2012Q4 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
25000000
CY2012Q4 us-gaap Construction In Progress Gross
ConstructionInProgressGross
2765000
CY2012Q4 us-gaap Capital Leases Future Minimum Payments Due Current
CapitalLeasesFutureMinimumPaymentsDueCurrent
5129000
CY2012Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2012Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
72666000
CY2012Q4 us-gaap Available For Sale Securities Fair Value Disclosure
AvailableForSaleSecuritiesFairValueDisclosure
252760000
CY2012Q4 us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Exercisable Options Weighted Average Exercise Price1
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1
9.03
CY2012Q4 us-gaap Debt And Capital Lease Obligations
DebtAndCapitalLeaseObligations
149000000
CY2012Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
1617744000
CY2012Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards Research
DeferredTaxAssetsTaxCreditCarryforwardsResearch
52769000
CY2012Q4 us-gaap Stockholders Equity
StockholdersEquity
47018000
CY2012Q4 us-gaap Capital Lease Obligations Noncurrent
CapitalLeaseObligationsNoncurrent
11607000
CY2012Q4 us-gaap Capital Leases Lessee Balance Sheet Assets By Major Class Accumulated Deprecation
CapitalLeasesLesseeBalanceSheetAssetsByMajorClassAccumulatedDeprecation
882000
CY2012Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
8407000
CY2012Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals
8776000
CY2012Q4 us-gaap Operating Leases Future Minimum Payments Due In Four Years
OperatingLeasesFutureMinimumPaymentsDueInFourYears
3777000
CY2012Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
2863000
CY2012Q4 nktr Cash And Cash Equivalents Including Restricted Cash
CashAndCashEquivalentsIncludingRestrictedCash
302200000
CY2012Q4 nktr Base Interest Rate
BaseInterestRate
0.17 pure
CY2012Q4 nktr Number Of Customers Accounted For Major Accounts Receivable
NumberOfCustomersAccountedForMajorAccountsReceivable
4 Customer
CY2012Q4 nktr Capital Leased Assets Net Book Value
CapitalLeasedAssetsNetBookValue
1400000
CY2012Q4 nktr Estimated Fair Value Of Cash Cash Equivalents And Available For Sale Investments
EstimatedFairValueOfCashCashEquivalentsAndAvailableForSaleInvestments
302194000
CY2012Q4 nktr Depreciable Property Plant And Equipment Gross
DepreciablePropertyPlantAndEquipmentGross
142116000
CY2012Q4 nktr Depreciable Property Plant And Equipment Net
DepreciablePropertyPlantAndEquipmentNet
69450000
CY2012Q4 nktr Deferred Tax Assets Capitalized Research Expenses
DeferredTaxAssetsCapitalizedResearchExpenses
7192000
CY2012Q4 nktr Deferred Tax Assets Depreciation Property And Equipment
DeferredTaxAssetsDepreciationPropertyAndEquipment
8482000
CY2012Q4 nktr Debt Instrument Convertible Retired Amount
DebtInstrumentConvertibleRetiredAmount
214955000
CY2012Q4 nktr License And Collaboration Agreements Potential Payments For Development Milestones
LicenseAndCollaborationAgreementsPotentialPaymentsForDevelopmentMilestones
161100000
CY2012Q4 nktr Liability Related To Sale Of Potential Future Royalties
LiabilityRelatedToSaleOfPotentialFutureRoyalties
128266000
CY2012Q4 nktr Accrued Clinical Trial Expenses
AccruedClinicalTrialExpenses
17500000
CY2012Q4 nktr Share Based Compensation Arrangement By Share Based Payment Award Options And Restricted Stock Units Outstanding
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndRestrictedStockUnitsOutstanding
19116000 shares
CY2012Q4 nktr Preferred Stock Share Designated
PreferredStockShareDesignated
0 shares
CY2012Q4 nktr Number Of Securities Available For Issuance Under Equity Compensation Plans
NumberOfSecuritiesAvailableForIssuanceUnderEquityCompensationPlans
10800000 shares
CY2012Q4 nktr Liability Related To Sale Of Potential Future Royalties Current
LiabilityRelatedToSaleOfPotentialFutureRoyaltiesCurrent
3000000
CY2012Q4 nktr Restricted Cash And Long Term Investments
RestrictedCashAndLongTermInvestments
25000000
CY2012Q4 nktr Liability Related To Sale Of Future Royalties Current And Noncurrent
LiabilityRelatedToSaleOfFutureRoyaltiesCurrentAndNoncurrent
131266000
CY2012Q4 nktr Cash And Money Market Funds Including Restricted Cash
CashAndMoneyMarketFundsIncludingRestrictedCash
49434000
CY2012Q4 nktr Deferred Tax Assets From Sale Of Future Royalties
DeferredTaxAssetsFromSaleOfFutureRoyalties
39750000
CY2010Q4 us-gaap Impaired Assets To Be Disposed Of By Method Other Than Sale Amount Of Impairment Loss
ImpairedAssetsToBeDisposedOfByMethodOtherThanSaleAmountOfImpairmentLoss
12600000
CY2010 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
827000
CY2010 us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans
8891000
CY2010 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-247000
CY2010 us-gaap Income Loss From Continuing Operations Before Income Taxes Foreign
IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
2264000
CY2010 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-577000
CY2010 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.40
CY2010 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
16713000
CY2010 us-gaap Investment Income Interest
InvestmentIncomeInterest
1545000
CY2010 us-gaap Unrecognized Tax Benefits Decreases Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsDecreasesResultingFromCurrentPeriodTaxPositions
CY2010 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
108065000
CY2010 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
-39321000
CY2010 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-47025000
CY2010 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
20301000
CY2010 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-37057000
CY2010 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Noncontrolling Interest
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToNoncontrollingInterest
-210000
CY2010 us-gaap Interest Paid
InterestPaid
10599000
CY2010 us-gaap Share Based Compensation
ShareBasedCompensation
17399000
CY2010 us-gaap Depreciation And Amortization
DepreciationAndAmortization
16551000
CY2010 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-31842000
CY2010 us-gaap Income Tax Reconciliation Tax Credits
IncomeTaxReconciliationTaxCredits
1833000
CY2010 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
2000
CY2010 us-gaap Available For Sale Securities Gross Realized Gains Losses Sale Proceeds
AvailableForSaleSecuritiesGrossRealizedGainsLossesSaleProceeds
15500000
CY2010 us-gaap Proceeds From Sale Of Available For Sale Securities
ProceedsFromSaleOfAvailableForSaleSecurities
15479000
CY2010 us-gaap Operating Income Loss
OperatingIncomeLoss
-28255000
CY2010 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-198000
CY2010 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
17399000
CY2010 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
551000
CY2010 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-57000
CY2010 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
795000
CY2010 us-gaap Cost Of Goods Sold
CostOfGoodsSold
25667000
CY2010 us-gaap Repayments Of Long Term Capital Lease Obligations
RepaymentsOfLongTermCapitalLeaseObligations
1356000
CY2010 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
180000
CY2010 us-gaap Net Income Loss
NetIncomeLoss
-37938000
CY2010 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-8802000
CY2010 us-gaap Costs And Expenses
CostsAndExpenses
187294000
CY2010 us-gaap Amortization Of Leased Asset
AmortizationOfLeasedAsset
14800000
CY2010 us-gaap Available For Sale Securities Change In Net Unrealized Holding Gain Loss
AvailableForSaleSecuritiesChangeInNetUnrealizedHoldingGainLoss
-267000
CY2010 us-gaap Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions
493000
CY2010 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
-800000
CY2010 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
40986000
CY2010 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
7535000
CY2010 us-gaap Royalty Revenue
RoyaltyRevenue
7255000
CY2010 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
15123000
CY2010 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-37995000
CY2010 us-gaap Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
475813000
CY2010 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
1000
CY2010 us-gaap Direct Operating Cost Royalty Expense
DirectOperatingCostRoyaltyExpense
2200000
CY2010 us-gaap Revenues
Revenues
159039000
CY2010 us-gaap Income Tax Examination Penalties And Interest Expense
IncomeTaxExaminationPenaltiesAndInterestExpense
0
CY2010 us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
473000
CY2010 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
881000
CY2010 us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
-219000
CY2010 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
31457000
CY2010 us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
12576000
CY2010 us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
1000000
CY2010 us-gaap Unrecognized Tax Benefits Decreases Resulting From Settlements With Taxing Authorities
UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities
CY2010 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
27412000
CY2010 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
701000
CY2010 us-gaap Payments To Acquire Available For Sale Securities
PaymentsToAcquireAvailableForSaleSecurities
443122000
CY2010 us-gaap Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
698000
CY2010 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
407000
CY2010 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
17399000
CY2010 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
19327000 shares
CY2010 us-gaap Deferred Foreign Income Tax Expense Benefit
DeferredForeignIncomeTaxExpenseBenefit
180000
CY2010 us-gaap Lease And Rental Expense
LeaseAndRentalExpense
2200000
CY2010 us-gaap Income Tax Reconciliation Foreign Income Tax Rate Differential
IncomeTaxReconciliationForeignIncomeTaxRateDifferential
86000
CY2010 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
1683000
CY2010 us-gaap Interest Expense
InterestExpense
11174000
CY2010 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
2000
CY2010 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
4274000
CY2010 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-12970000
CY2010 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-55871000
CY2010 nktr Property And Equipment Acquired Through Capital Leases
PropertyAndEquipmentAcquiredThroughCapitalLeases
195000
CY2010 nktr License Collaboration Other Revenue
LicenseCollaborationOtherRevenue
124372000
CY2010 nktr Increase Decrease In Accrued Clinical Trial Expenses
IncreaseDecreaseInAccruedClinicalTrialExpenses
-2023000
CY2010 nktr Weighted Average Shares Outstanding Used In Computing Basic And Diluted Net Loss Per Share
WeightedAverageSharesOutstandingUsedInComputingBasicAndDilutedNetLossPerShare
94079000 shares
CY2010 nktr Stock Option Exercises And Restricted Stock Units Release
StockOptionExercisesAndRestrictedStockUnitsRelease
8340000
CY2011 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-1044000
CY2011 us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans
4530000
CY2011 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-943000
CY2011 us-gaap Income Loss From Continuing Operations Before Income Taxes Foreign
IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
2920000
CY2011 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
12267000
CY2011 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-1.19
CY2011 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-111952000
CY2011 us-gaap Investment Income Interest
InvestmentIncomeInterest
2244000
CY2011 us-gaap Unrecognized Tax Benefits Decreases Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsDecreasesResultingFromCurrentPeriodTaxPositions
CY2011 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
126766000
CY2011 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
-135880000
CY2011 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-17516000
CY2011 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-20164000
CY2011 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-132960000
CY2011 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Noncontrolling Interest
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToNoncontrollingInterest
1288000
CY2011 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
52900000
CY2011 us-gaap Interest Paid
InterestPaid
10277000
CY2011 us-gaap Share Based Compensation
ShareBasedCompensation
18885000
CY2011 us-gaap Depreciation And Amortization
DepreciationAndAmortization
14951000
CY2011 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-2443000
CY2011 us-gaap Income Tax Reconciliation Tax Credits
IncomeTaxReconciliationTaxCredits
893000
CY2011 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
1000
CY2011 us-gaap Available For Sale Securities Gross Realized Gains Losses Sale Proceeds
AvailableForSaleSecuritiesGrossRealizedGainsLossesSaleProceeds
210100000
CY2011 us-gaap Proceeds From Sale Of Available For Sale Securities
ProceedsFromSaleOfAvailableForSaleSecurities
210089000
CY2011 us-gaap Operating Income Loss
OperatingIncomeLoss
-123937000
CY2011 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-1359000
CY2011 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
18885000
CY2011 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
614000
CY2011 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-2071000
CY2011 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
5390000
CY2011 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-113742000
CY2011 us-gaap Cost Of Goods Sold
CostOfGoodsSold
21891000
CY2011 us-gaap Repayments Of Long Term Capital Lease Obligations
RepaymentsOfLongTermCapitalLeaseObligations
1978000
CY2011 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
96000
CY2011 us-gaap Net Income Loss
NetIncomeLoss
-133978000
CY2011 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-9023000
CY2011 us-gaap Stock Issued During Period Value Other
StockIssuedDuringPeriodValueOther
617000
CY2011 us-gaap Costs And Expenses
CostsAndExpenses
195417000
CY2011 us-gaap Amortization Of Leased Asset
AmortizationOfLeasedAsset
15000000
CY2011 us-gaap Available For Sale Securities Change In Net Unrealized Holding Gain Loss
AvailableForSaleSecuritiesChangeInNetUnrealizedHoldingGainLoss
-783000
CY2011 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
3555000
CY2011 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
46760000
CY2011 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
222335000
CY2011 us-gaap Royalty Revenue
RoyaltyRevenue
10327000
CY2011 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
48959000
CY2011 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-136049000
CY2011 us-gaap Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
383052000
CY2011 us-gaap Direct Operating Cost Royalty Expense
DirectOperatingCostRoyaltyExpense
1800000
CY2011 us-gaap Revenues
Revenues
71480000
CY2011 us-gaap Income Tax Examination Penalties And Interest Expense
IncomeTaxExaminationPenaltiesAndInterestExpense
0
CY2011 us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
-384000
CY2011 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1018000
CY2011 us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
916000
CY2011 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
219783000
CY2011 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
9722000
CY2011 us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
900000
CY2011 us-gaap Unrecognized Tax Benefits Decreases Resulting From Settlements With Taxing Authorities
UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities
CY2011 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
24864000
CY2011 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
922000
CY2011 us-gaap Payments To Acquire Available For Sale Securities
PaymentsToAcquireAvailableForSaleSecurities
695371000
CY2011 us-gaap Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
921000
CY2011 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
957000
CY2011 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
18885000
CY2011 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
21327000 shares
CY2011 us-gaap Deferred Foreign Income Tax Expense Benefit
DeferredForeignIncomeTaxExpenseBenefit
96000
CY2011 us-gaap Lease And Rental Expense
LeaseAndRentalExpense
2400000
CY2011 us-gaap Income Tax Reconciliation Foreign Income Tax Rate Differential
IncomeTaxReconciliationForeignIncomeTaxRateDifferential
-129000
CY2011 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
1013000
CY2011 us-gaap Interest Expense
InterestExpense
10223000
CY2011 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
1000
CY2011 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-3384000
CY2011 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
219783000
CY2011 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-46536000
CY2011 nktr Valuation Allowance Related To Stock Based Compensation And Exercises
ValuationAllowanceRelatedToStockBasedCompensationAndExercises
35600000
CY2011 nktr License Collaboration Other Revenue
LicenseCollaborationOtherRevenue
36289000
CY2011 nktr Increase Decrease In Accrued Clinical Trial Expenses
IncreaseDecreaseInAccruedClinicalTrialExpenses
-191000
CY2011 nktr Percentage Of Accounts Receivable Customers Four
PercentageOfAccountsReceivableCustomersFour
0.17 pure
CY2011 nktr Percentage Of Accounts Receivable Customers One
PercentageOfAccountsReceivableCustomersOne
0.26 pure
CY2011 nktr Percentage Of Accounts Receivable Customers Three
PercentageOfAccountsReceivableCustomersThree
0.19 pure
CY2011 nktr Percentage Of Accounts Receivable Customers Two
PercentageOfAccountsReceivableCustomersTwo
0.20 pure
CY2012 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-1.50
CY2012 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
113020000
CY2012 us-gaap Investment Income Interest
InvestmentIncomeInterest
2315000
CY2011 nktr Weighted Average Shares Outstanding Used In Computing Basic And Diluted Net Loss Per Share
WeightedAverageSharesOutstandingUsedInComputingBasicAndDilutedNetLossPerShare
112942000 shares
CY2011 nktr Stock Option Exercises And Restricted Stock Units Release
StockOptionExercisesAndRestrictedStockUnitsRelease
3916000
CY2012 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2012 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2012 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2012
CY2012 dei Document Type
DocumentType
10-K
CY2012 dei Document Period End Date
DocumentPeriodEndDate
2012-12-31
CY2012 dei Entity Central Index Key
EntityCentralIndexKey
0000906709
CY2012 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
Yes
CY2012 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2012 dei Trading Symbol
TradingSymbol
NKTR
CY2012 dei Entity Registrant Name
EntityRegistrantName
NEKTAR THERAPEUTICS
CY2012 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2012 dei Amendment Flag
AmendmentFlag
false
CY2012 dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
CY2012 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
983000
CY2012 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
-49000
CY2012 us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans
4117000
CY2012 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
3275000
CY2012 us-gaap Income Loss From Continuing Operations Before Income Taxes Foreign
IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
2809000
CY2012 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-6031000
CY2012 us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
4500000
CY2012 us-gaap Available For Sale Securities Income Tax Expense On Change In Unrealized Holding Gain Or Loss
AvailableForSaleSecuritiesIncomeTaxExpenseOnChangeInUnrealizedHoldingGainOrLoss
470000
CY2012 us-gaap Unrecognized Tax Benefits Decreases Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsDecreasesResultingFromCurrentPeriodTaxPositions
CY2012 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P1Y7M6D
CY2012 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
148675000
CY2012 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
-174258000
CY2012 us-gaap Income Tax Reconciliation Nondeductible Expense Other
IncomeTaxReconciliationNondeductibleExpenseOther
6320000
CY2012 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-9384000
CY2012 us-gaap Repayments Of Subordinated Debt
RepaymentsOfSubordinatedDebt
172407000
CY2012 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
867000
CY2012 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-171449000
CY2012 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Noncontrolling Interest
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToNoncontrollingInterest
-10000
CY2012 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
43600000
CY2012 us-gaap Interest Paid
InterestPaid
9620000
CY2012 us-gaap Share Based Compensation
ShareBasedCompensation
16199000
CY2012 us-gaap Depreciation And Amortization
DepreciationAndAmortization
14508000
CY2012 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
10125000
CY2012 us-gaap Income Tax Reconciliation Tax Credits
IncomeTaxReconciliationTaxCredits
591000
CY2012 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
1000
CY2012 us-gaap Available For Sale Securities Gross Realized Gains Losses Sale Proceeds
AvailableForSaleSecuritiesGrossRealizedGainsLossesSaleProceeds
5400000
CY2012 us-gaap Proceeds From Sale Of Available For Sale Securities
ProceedsFromSaleOfAvailableForSaleSecurities
5378000
CY2012 us-gaap Operating Income Loss
OperatingIncomeLoss
-141201000
CY2012 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-845000
CY2012 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
16199000
CY2012 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
746000
CY2012 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
5613000
CY2012 us-gaap Cost Of Goods Sold
CostOfGoodsSold
30428000
CY2012 us-gaap Repayments Of Long Term Capital Lease Obligations
RepaymentsOfLongTermCapitalLeaseObligations
2437000
CY2012 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-487000
CY2012 us-gaap Net Income Loss
NetIncomeLoss
-171855000
CY2012 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-30248000
CY2012 us-gaap Costs And Expenses
CostsAndExpenses
222392000
CY2012 us-gaap Amortization Of Leased Asset
AmortizationOfLeasedAsset
13800000
CY2012 us-gaap Available For Sale Securities Change In Net Unrealized Holding Gain Loss
AvailableForSaleSecuritiesChangeInNetUnrealizedHoldingGainLoss
1206000
CY2012 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
-4034000
CY2012 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
41614000
CY2012 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
26801000
CY2012 us-gaap Royalty Revenue
RoyaltyRevenue
4874000
CY2012 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
47349000
CY2012 us-gaap Proceeds From Issuance Of Secured Debt
ProceedsFromIssuanceOfSecuredDebt
77940000
CY2012 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.35 pure
CY2012 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-171109000
CY2012 us-gaap Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
307887000
CY2012 us-gaap Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations
UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations
137000
CY2012 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
-137000
CY2012 us-gaap Direct Operating Cost Royalty Expense
DirectOperatingCostRoyaltyExpense
2900000
CY2012 us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
5278000
CY2012 us-gaap Revenues
Revenues
81191000
CY2012 us-gaap Income Tax Examination Penalties And Interest Expense
IncomeTaxExaminationPenaltiesAndInterestExpense
0
CY2012 us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
1100000
CY2012 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
406000
CY2012 us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
60000
CY2012 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
4117000
CY2012 us-gaap Deferred Compensation Arrangement With Individual Employer Contribution
DeferredCompensationArrangementWithIndividualEmployerContribution
3000
CY2012 us-gaap Increase Decrease In Restricted Cash
IncreaseDecreaseInRestrictedCash
25000000
CY2012 us-gaap Debt Conversion Original Debt Amount1
DebtConversionOriginalDebtAmount1
42548000
CY2012 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
10583000
CY2012 us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
1675000
CY2012 us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
900000
CY2012 us-gaap Unrecognized Tax Benefits Decreases Resulting From Settlements With Taxing Authorities
UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities
CY2012 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
35399000
CY2012 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
893000
CY2012 us-gaap Payments To Acquire Available For Sale Securities
PaymentsToAcquireAvailableForSaleSecurities
164662000
CY2012 us-gaap Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
1029000
CY2012 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
1021000
CY2012 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
16199000
CY2012 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
13970000 shares
CY2012 us-gaap Deferred Foreign Income Tax Expense Benefit
DeferredForeignIncomeTaxExpenseBenefit
-16000
CY2012 us-gaap Lease And Rental Expense
LeaseAndRentalExpense
2800000
CY2012 us-gaap Income Tax Reconciliation Foreign Income Tax Rate Differential
IncomeTaxReconciliationForeignIncomeTaxRateDifferential
-227000
CY2012 us-gaap Income Tax Reconciliation Tax Settlements Foreign
IncomeTaxReconciliationTaxSettlementsForeign
6510000
CY2012 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
1495000
CY2012 us-gaap Interest Expense
InterestExpense
15489000
CY2012 us-gaap Impaired Assets To Be Disposed Of By Method Other Than Sale Method For Determining Fair Value
ImpairedAssetsToBeDisposedOfByMethodOtherThanSaleMethodForDeterminingFairValue
Probability-weighted discounted cash flow model of the future estimated net sublease income
CY2012 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
-48000
CY2012 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-122000
CY2012 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-60007000
CY2012 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
-422000
CY2012 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-129756000
CY2012 nktr Proceeds From Issuance Of Senior Notes
ProceedsFromIssuanceOfSeniorNotes
125000000
CY2012 nktr Noncash Interest Expense
NoncashInterestExpense
18057000
CY2012 nktr Redemption Price As Percentage Of Principal Amount In Case Of Change Of Control
RedemptionPriceAsPercentageOfPrincipalAmountInCaseOfChangeOfControl
1.01 pure
CY2012 nktr Capital Leases Termination Date
CapitalLeasesTerminationDate
2016-10-05
CY2012 nktr Sublease Term Commenced End Date
SubleaseTermCommencedEndDate
January 31, 2020
CY2012 nktr Sublease Term Commenced Start Date
SubleaseTermCommencedStartDate
August 2010
CY2012 nktr Sublease Term Commenced Period
SubleaseTermCommencedPeriod
114 months
CY2012 nktr Severance Payment Period For Employees
SeverancePaymentPeriodForEmployees
6 months
CY2012 nktr Severance Payment Period For Executives
SeverancePaymentPeriodForExecutives
12 months
CY2012 nktr Unrecognized Tax Benefits Period Increase Decrease Reasonable Period Of Change
UnrecognizedTaxBenefitsPeriodIncreaseDecreaseReasonablePeriodOfChange
Next twelve months
CY2012 nktr Maturity Term Of Investments In Marketable Securities To Be Considered As Cash Equivalents
MaturityTermOfInvestmentsInMarketableSecuritiesToBeConsideredAsCashEquivalents
Three months
CY2012 nktr Number Of Components Within Business Segment
NumberOfComponentsWithinBusinessSegment
2 Segment
CY2012 nktr Number Of Operating Business Segment
NumberOfOperatingBusinessSegment
1 Segment
CY2012 nktr Proceeds From Sale Of Potential Future Royalties
ProceedsFromSaleOfPotentialFutureRoyalties
124000000
CY2012 nktr Proceeds From Sale Of Potential Future Royalties Net Of Transaction Costs
ProceedsFromSaleOfPotentialFutureRoyaltiesNetOfTransactionCosts
119588000
CY2012 nktr Valuation Allowance Related To Stock Based Compensation And Exercises
ValuationAllowanceRelatedToStockBasedCompensationAndExercises
35600000
CY2012 nktr Operating Lease Expense Per Month After Amendment
OperatingLeaseExpensePerMonthAfterAmendment
40000
CY2012 nktr Noncash Interest Expense On Liability From Sale Of Royalties
NoncashInterestExpenseOnLiabilityFromSaleOfRoyalties
18057000
CY2012 nktr Non Cash Royalty Revenue Related To Sale Of Future Royalties
NonCashRoyaltyRevenueRelatedToSaleOfFutureRoyalties
10791000
CY2012 nktr License Collaboration Other Revenue
LicenseCollaborationOtherRevenue
30127000
CY2012 nktr Initial Monthly Base Rent
InitialMonthlyBaseRent
2.95
CY2012 nktr Increase Decrease In Accrued Clinical Trial Expenses
IncreaseDecreaseInAccruedClinicalTrialExpenses
5547000
CY2012 nktr Final Monthly Base Rent
FinalMonthlyBaseRent
3.42
CY2012 nktr Federal Orphan Drug Credits
FederalOrphanDrugCredits
14000000
CY2012 nktr Maximum Contribution Per Employee Annual Salary Percentage
MaximumContributionPerEmployeeAnnualSalaryPercentage
0.60 pure
CY2012 nktr Percentage Of Amount Realized Upon Ultimate Settlement
PercentageOfAmountRealizedUponUltimateSettlement
0.50 pure
CY2012 nktr Percentage Ceiling On Rent Increase
PercentageCeilingOnRentIncrease
0.03 pure
CY2012 nktr Percentage Of Accounts Receivable Customers Four
PercentageOfAccountsReceivableCustomersFour
0.11 pure
CY2012 nktr Percentage Of Accounts Receivable Customers One
PercentageOfAccountsReceivableCustomersOne
0.38 pure
CY2012 nktr Percentage Of Accounts Receivable Customers Three
PercentageOfAccountsReceivableCustomersThree
0.14 pure
CY2012 nktr Percentage Of Accounts Receivable Customers Two
PercentageOfAccountsReceivableCustomersTwo
0.27 pure
CY2012 nktr Weighted Average Shares Outstanding Used In Computing Basic And Diluted Net Loss Per Share
WeightedAverageSharesOutstandingUsedInComputingBasicAndDilutedNetLossPerShare
114820000 shares
CY2012 nktr Cash Severance Payment For To Chief Executive Officer
CashSeverancePaymentForToChiefExecutiveOfficer
24 months base salary plus annual target incentive pay
CY2012 nktr Debt Instrument Maximum Maturity Period
DebtInstrumentMaximumMaturityPeriod
Two years or less
CY2012 nktr Maturity Term Of Investments Considered As Short Term
MaturityTermOfInvestmentsConsideredAsShortTerm
Less than one year
CY2012 nktr Restricted Stock Units Award Depletion Ratio
RestrictedStockUnitsAwardDepletionRatio
1:1.5
CY2012 nktr Debt Instrument Weighted Average Maturity Period1
DebtInstrumentWeightedAverageMaturityPeriod1
One year or less
CY2012 nktr Redemption Price As Percentage Of Principal Amount In Case Of Sale Of Assets
RedemptionPriceAsPercentageOfPrincipalAmountInCaseOfSaleOfAssets
1.00 pure
CY2012 nktr Payment For Transaction Costs
PaymentForTransactionCosts
4400000
CY2011Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.33
CY2011Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
30176000
CY2011Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-33867000
CY2011Q1 us-gaap Cost Of Goods Sold
CostOfGoodsSold
3263000
CY2011Q1 us-gaap Net Income Loss
NetIncomeLoss
-36034000
CY2011Q1 us-gaap Revenues
Revenues
11299000
CY2011Q1 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
2474000
CY2011Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.32
CY2011Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
32270000
CY2011Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-34264000
CY2011Q2 us-gaap Cost Of Goods Sold
CostOfGoodsSold
8140000
CY2011Q2 us-gaap Net Income Loss
NetIncomeLoss
-36381000
CY2011Q2 us-gaap Revenues
Revenues
17331000
CY2011Q2 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
8641000
CY2012Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.36
CY2012Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
35085000
CY2012Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-37932000
CY2012Q1 us-gaap Cost Of Goods Sold
CostOfGoodsSold
8707000
CY2012Q1 us-gaap Net Income Loss
NetIncomeLoss
-41097000
CY2012Q1 us-gaap Revenues
Revenues
17949000
CY2012Q1 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
6945000
CY2012Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.30
CY2012Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
33201000
CY2012Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-26988000
CY2012Q2 us-gaap Cost Of Goods Sold
CostOfGoodsSold
7203000
CY2012Q2 us-gaap Net Income Loss
NetIncomeLoss
-34285000
CY2012Q2 us-gaap Revenues
Revenues
23684000
CY2012Q2 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
9694000
CY2011Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.21
CY2011Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
31018000
CY2011Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-21338000
CY2011Q3 us-gaap Cost Of Goods Sold
CostOfGoodsSold
5038000
CY2011Q3 us-gaap Net Income Loss
NetIncomeLoss
-24068000
CY2011Q3 us-gaap Revenues
Revenues
27068000
CY2011Q3 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
7677000
CY2012Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.38
CY2012Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
34016000
CY2012Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-32900000
CY2012Q3 us-gaap Cost Of Goods Sold
CostOfGoodsSold
7228000
CY2012Q3 us-gaap Net Income Loss
NetIncomeLoss
-43547000
CY2012Q3 us-gaap Revenues
Revenues
18412000
CY2012Q3 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
8355000
CY2011Q4 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.33
CY2011Q4 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
33302000
CY2011Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
-34468000
CY2011Q4 us-gaap Cost Of Goods Sold
CostOfGoodsSold
5450000
CY2011Q4 us-gaap Net Income Loss
NetIncomeLoss
-37495000
CY2011Q4 us-gaap Revenues
Revenues
15782000
CY2011Q4 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
6073000
CY2012Q4 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.46
CY2012Q4 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
46373000
CY2012Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
-43381000
CY2012Q4 us-gaap Cost Of Goods Sold
CostOfGoodsSold
7290000
CY2012Q4 us-gaap Net Income Loss
NetIncomeLoss
-52926000
CY2012Q4 us-gaap Revenues
Revenues
21146000
CY2012Q4 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
10405000

Files In Submission

Name View Source Status
0001193125-13-085500-index-headers.html Edgar Link pending
0001193125-13-085500-index.html Edgar Link pending
0001193125-13-085500.txt Edgar Link pending
0001193125-13-085500-xbrl.zip Edgar Link pending
d448841d10k.htm Edgar Link pending
d448841dex1024.htm Edgar Link pending
d448841dex106.htm Edgar Link pending
d448841dex107.htm Edgar Link pending
d448841dex211.htm Edgar Link pending
d448841dex231.htm Edgar Link pending
d448841dex311.htm Edgar Link pending
d448841dex312.htm Edgar Link pending
d448841dex321.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xls Edgar Link pending
g448841g37d80.jpg Edgar Link pending
nktr-20121231.xml Edgar Link completed
nktr-20121231.xsd Edgar Link pending
nktr-20121231_cal.xml Edgar Link unprocessable
nktr-20121231_def.xml Edgar Link unprocessable
nktr-20121231_lab.xml Edgar Link unprocessable
nktr-20121231_pre.xml Edgar Link unprocessable
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R75.htm Edgar Link pending
R76.htm Edgar Link pending
R77.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending